However, the vvDD-IL-9 treatment significantly elevated the levels of IL-10 mRNA in the tumor on day 9 (Figure 5C), suggesting that secondary IL-10 upregulation might enhance the persistence of vvDD-IL-9 in the tumor. Here, IL10 is linked to neoplasm.